Breast cancer surgery-induced immunomodulation

Journal of Surgical Oncology

Volumn 102, Issue 6, 2010, Pages 640-648

  Boomsma, Martijn F ^a   Garssen, Bert ^a   Slot, Edith ^b   Berbee, Monique ^c   Berkhof, Johannes ^b   Meezenbroek, Eltica De Jager ^a   Slieker, Walentina ^c   Visser, Adriaan ^d   Meijer, Sybren ^b   Beelen, Robert H J ^b  

^a HELEN DOWLING INSTITUTE   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Location Alkmaar   (Netherlands)

^d ROTTERDAM UNIVERSITY OF APPLIED SCIENCES   (Netherlands)

Author keywords

cortisol; cytokines; cytotoxicity

Indexed keywords

HLA DR ANTIGEN; HYDROCORTISONE; ONDANSETRON; PARACETAMOL; PIRITRAMIDE; TEMAZEPAM;

ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER PATIENT; CLINICAL ARTICLE; ENDOCRINE FUNCTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; LYMPH NODE DISSECTION; MASTECTOMY; NATURAL KILLER CELL; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

BREAST NEOPLASMS; C-REACTIVE PROTEIN; CYTOKINES; FEMALE; HUMANS; HYDROCORTISONE; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; IMMUNOMODULATION;

EID: 78349238465     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21662     Document Type: Article

References (38)

1. McCulloch P, Choy A, Martin L:, Association between tumour angiogenesis and tumour cell shedding into effluent venous blood during breast cancer surgery. Lancet 1995; 346: 1334-1335.
2. Goldfarb Y, Ben-Eliyahu S:, Surgery as a risk factor for breast cancer recurrence and metastasis: Mediating mechanisms and clinical prophylactic approaches. Breast Dis 2006; 26: 99-114.
3. Ben-Eliyahu S:, The promotion of tumor metastasis by surgery and stress: Immunological basis and implications for psychoneuroimmunology. Brain Behav Immune 2003; 17: S27-S36.
4. Weissman C:, The metabolic response to stress: An overview and update. Anesthesiology 1990; 73: 308-327.
5. Naito Y, Tamai S, Shingu K, et al.: Responses of plasma adrenocorticotropic hormone, cortisol, and cytokines during and after upper abdominal surgery. Anesthesiology 1992; 77: 426-431.
6. Fishman P, Nedivi R, Djaldetti M, et al.: Kinetics of cortisol, interleukine-2 and interleukine-3-like activity levels following surgical intervention. Nat Immun Cell Growth Regul 1993; 12: 35-40.
7. Shakhar G, Ben-Eliyahu S:, Potential prophylactic measures against postoperative immunosuppression: Could they reduce recurrence rates in oncological patients ? Ann Surg Oncol 2003; 10: 972-992.
8. Naito Y, Fukata J, Tamai S, et al.: Biphasic changes of the hypothalamic-pituitary-adrenal function during the early recovery period after major abdominal surgery. J Clin Endocrinol Metab 1991; 73: 111-117.
9. Hanna N:, The role of natural killer cells in the control of tumor growth and metastases. Biochim Biophys Acta 1985; 780: 213-226.
10. Ben-Eliyahu S, Yirmiya R, Liebeskind JC, et al.: Stress increases metastatic spread of a mammary tumor in rats: Evidence for mediation by the immune system. Brain Behav Immun 1991; 5: 193-205.
11. Ben-Eliyahu S, Page GG, Yirmiya R, et al.: Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer 1999; 80: 880-888.
12. Fawzy FI, Fawzy NW, Hyun CS, et al.: Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 1993; 50: 681-689.
13. Levy SM, Herberman RB, Lippman M, et al.: Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer. Behav Med 1991; 17: 67-75.
14. Schantz SP, Ordonez NG:, Quantitation of natural-killer-cell function and risk of metastatic poorly differentiated head and neck-cancer. Nat Immune Cell Growth Regul 1991; 10: 278-288.
15. Kloosterman T, Vonblomberg BME, Borgstein P, et al.: Unimpaired immune functions after laparoscopic cholecystectomy. Surgery 1994; 115: 424-428.
16. Pollock RE, Lotzova E, Stanford SD:, Surgical stress impairs natural killer cell programming of tumor lysis in patients with sarcomas and other solid tumors. Cancer 1992; 70: 2192-2201.
17. Schuurman B, Beelen RHJ, Meijer S:, Adjuvant treatment in surgery: Colorectal cancer. Manual of GM-CSF. Edinburgh, UK: Blackwell Science; 1996.
18. Uchida A, Kolb R, Micksche M:, Generation of suppressor cells for natural killer activity in cancer patients after surgery. J Nat Cancer Inst 1982; 68: 735-741. (Pubitemid 12070927)
19. Khan AL, Richardson S, Drew J, et al.: Polyadenylic-polyuridylic acid enhances the natural cell-mediated cytotoxicity in patients with breast-cancer undergoing mastectomy. Surgery 1995; 118: 531-538.
20. Mcculloch PG, Macintyre A:, Effects of surgery on the generation of lymphokine-activated killer-cells in patients with breast-cancer. Brit J Surg 1993; 80: 1005-1007.
21. Beitsch P, Lotzova E, Hortobagyi G, et al.: Natural immunity in breast-cancer patients during neoadjuvant chemotherapy and after surgery. Surg Oncol 1994; 3: 211-219.
22. Tjemsland L, Soreide JA, Matre R, et al.: Preoperative psychological variables predict immunological status in patients with operable breast cancer. Psycho-Oncology 1997; 6: 311-320.
23. Khan AL, Larsen F, Heys SD, et al.: Peri-operative acute phase response and cytokine release in women with breast cancer: Modulation by polyadenylic-polyuridylic acid. Eur J Surg Oncol 1999; 25: 574-579.
24. Stanojevic-Bakic N, Vuckovic-Dekic L, Radomirovic S, et al.: The influence of surgery and anesthesia on lymphocyte functions in breast cancer patients: In vitro effects of indomethacin. Neoplasma 1999; 46: 54-60.
25. Larson MR, Duberstein PR, Talbot NL, et al.: A presurgical psychosocial intervention for breast cancer patients: Password psychological distress and the immune response. J Psychosom Res 2000; 48: 187-194.
26. Holden JE, Kelley K, Agarwal R:, Analyzing change: A primer on multilevel models with applications to nephrology. Am J Nephrol 2008; 28: 792-801.
27. Ballou SP, Kushner I:, C-reactive protein and the acute-phase response. Adv Int Med 1992; 37: 313-336.
28. Mehigan BJ, Hartley JE, Drew PJ, et al.: Changes in T cell subsets, interleukin-6, and C-reactive protein after laparoscopic and open colorectal resection for malignancy. Surg Endosc 2001; 15: 1289-1293.
29. 2 vs helium insufflation or the abdominal wall lifting technique on the systemic immune response. Surg Endosc 2002; 16: 525-528.
30. Sietses C, Wiezer MJ, Eijsbouts QAJ, et al.: A prospective randomized study of the systemic immune response after laparoscopic and conventional Nissen fundoplication. Surgery 1999; 126: 5-9.
31. Melamed R, Rosenne E, Shakhar K, et al.: Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: Suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain Behav Immun 2005; 19: 114-126.
32. Luecken LJ, Compas BE:, Stress, coping, and immune function in breast cancer. Ann Behavioral Med 2002; 24: 336-344.
33. Schuurman B, Koenen HJ, Beelen RHJ, et al.: Granulocyte macrophage colony stimulating factor pretreatment induces an increase of rat Kupffer cells with enhanced cytotoxicity in vitro and prevention of tumor outgrowth in vivo. Anti-Cancer Drugs 1997; 8: 269-275.
34. Polk HC:, Monocyte expression of class-II antigens. Brit J Surg 1993; 80: 138-140.
35. Brune IB, Wilke W, Hensler T, et al.: Normal T lymphocyte and monocyte function after minimally invasive surgery. Surg Endosc 1998; 12: 1020-1024.
36. Ben-Eliyahu S:, Does surgery promote metastasis ? Lancet Oncol 2002; 3: 578-579.
37. van der Bij GJ, Oosterling SJ, Beelen RHJ, et al.: The perioperative period is an underutilized window of therapeutic opportunity in patients with colorectal cancer. Ann Surg 2009; 249: 727-734.
38. Morrow M:, Minimally invasive surgery for breast cancer. Brit Med J 2009; 338: 845-846.